Dr. Willmar Schwabe Pharmaceuticals Will Acquire Enzymatic Therapy, Inc., USA
The transaction was completed by Lincoln International, a leading mid-market investment bank, who acted as the exclusive financial advisor to Schwabe Pharmaceuticals and Nature’s Way, working directly with the Board of Directors and senior management teams of both companies.
According to the company, the combination of these organizations brings together leading industry professionals across every business discipline and creates an unsurpassed portfolio of clinically validated natural products and ingredients. The group will build upon the advanced research and development capabilities of each of the entities to create a new standard in natural health enhancement.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.